Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Wockhardt Limited
No Price
Closing Price XNSE 29.04.2026:
1.386,80 INR
29.04.2026 08:58
Current Prices from Wockhardt Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
WOCKPHARMA.NS
INR
29.04.2026 08:58
1.386,80 INR
-30,35 INR
-2,14 %
MSE
WOCKPHARMA.BO
INR
29.04.2026 08:41
1.384,95 INR
-32,20 INR
-2,27 %
Share Float & Liquidity
Free Float47,35 %
Shares Float76,93 M
Shares Outstanding162,49 M
Company Profile for Wockhardt Limited Share
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables, lyophilization, and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
